Inlyta (Axitinib)

This is a type of medicine used to treat certain types of kidney cancer. It works by blocking a specific protein (tyrosine kinase) that helps cancer cells grow. It is often used when other treatments haven't worked.

Brand names:Inlyta
Medication

What people taking Inlyta (Axitinib) report

Every report comes from a Lived member, sent anonymously.

Have you tried Inlyta (Axitinib) for Renal Cell Carcinoma?

NameHow it went

About Inlyta (Axitinib)

What It's For

Axitinib, sold under the brand name Inlyta, is a prescription cancer pill used to treat advanced renal cell carcinoma (RCC), a cancer that begins in the cells of the kidney. "Advanced" here means the cancer has spread beyond the kidney or cannot be removed with surgery. It is used in two situations. As a first treatment for advanced RCC, it is combined with an immunotherapy drug given through a vein (IV infusion): either pembrolizumab (Keytruda) or avelumab (Bavencio). Immunotherapy helps the immune system recognize and attack cancer, and pairing it with axitinib attacks the cancer in two different ways. Axitinib can also be used on its own when advanced RCC has grown despite one earlier cancer treatment. Axitinib is not a cure for advanced kidney cancer. Its purpose is to shrink tumors or keep them from growing for as long as possible, and in some combinations, to help people live longer.

How It Works

Tumors need a growing blood supply to bring them oxygen and nutrients. They send out a signal called VEGF (vascular endothelial growth factor) that tells nearby blood vessels to sprout new branches. Axitinib is a kinase inhibitor, a drug that blocks specific proteins cells use to pass along growth messages. It blocks the receptors that receive the VEGF signal, which slows the formation of new blood vessels feeding the tumor and can starve it of what it needs to grow. The same blood vessel signals also help control blood pressure, kidney filtering, wound repair and the lining of blood vessels throughout the body. That is why many of axitinib's side effects, such as high blood pressure, protein in the urine and slower wound healing, follow directly from how it works.

Dosage & Administration

Axitinib comes as tablets taken by mouth twice a day, about 12 hours apart, with or without food. The tablets are swallowed whole with a glass of water, not split, chewed or crushed. When it is combined with immunotherapy, the pills are taken at home while the pembrolizumab or avelumab infusion is given at a clinic on its own schedule, every few weeks. Treatment usually starts at a standard dose. If someone tolerates it well, has normal blood pressure and does not need blood pressure medicine, the oncologist may raise the dose in steps. If side effects become a problem, the dose can be paused or lowered. A lower starting dose is used for people with moderate liver problems, and dose changes are also needed if certain interacting medicines cannot be avoided. If a dose is missed or vomited, do not take an extra one. Take the next dose at the usual time.

Side Effects

Diarrhea, tiredness, high blood pressure, loss of appetite, nausea and a hoarse or changed voice are among the most common side effects. Many people also get hand-foot syndrome, which causes redness, soreness, tingling or peeling on the palms and soles. Weight loss, mouth sores, constipation and an underactive thyroid (which can add to tiredness and feeling cold) are also common. Most of these are managed with supportive care or dose adjustments rather than by stopping treatment. Blood pressure deserves particular attention. It can rise within the first few days and most often climbs during the first month, so it should be well controlled before starting and checked regularly, often at home. Some people need to start or adjust blood pressure medicine. Serious side effects are less common, and most trace back to the drug's effect on blood vessels. Get emergency care for any of the following. Chest pain or pressure, sudden or severe shortness of breath, or sudden weakness on one side, trouble speaking or vision loss can signal a clot in the heart, lungs or brain. Vomiting blood or material that looks like coffee grounds, or black, tarry stools, can signal serious bleeding. Severe or persistent abdominal pain can mean a rare tear in the bowel. A seizure, or a severe headache with confusion, can signal a rare brain-swelling condition. Call the care team promptly for a swollen, warm or red leg (a possible clot in a vein), breathlessness that builds gradually or new ankle swelling (possible heart strain), or yellowing of the skin or eyes, dark urine or pain in the upper right abdomen (possible liver injury). Other unusual bleeding, such as nosebleeds that won't stop or blood in the urine, should also be reported promptly.

Interactions & Warnings

The liver breaks down axitinib using a specific group of enzymes. Medicines that strongly block these enzymes, such as the antifungal ketoconazole, can push axitinib levels too high, and grapefruit or grapefruit juice can do the same, so grapefruit should be avoided. Medicines that speed these enzymes up, such as the antibiotic rifampin, some seizure medicines (phenytoin, carbamazepine) and the herbal supplement St. John's wort, can lower axitinib levels and make it less effective. Share a full list of prescriptions, over-the-counter products and supplements with the oncologist and pharmacist, and check before starting anything new. Axitinib raises the risk of bleeding and is not used in people with untreated cancer spread to the brain or recent active bleeding in the stomach or intestines. It also slows wound healing, so it is stopped at least 2 days before planned surgery, including dental surgery, and not restarted for at least 2 weeks after major surgery and until the wound has healed. Tell any surgeon or dentist about it. People with a recent stroke, heart attack or blood clot, or with heart failure, need a careful discussion of risks, because the drug can increase these problems. Axitinib can harm a developing baby. For axitinib itself, people who could become pregnant should use effective birth control during treatment and for 1 week after the last dose, men with partners who could become pregnant should do the same, and breastfeeding is not recommended until 2 weeks after the last dose. When axitinib is combined with pembrolizumab or avelumab, the immunotherapy needs a longer window after its last infusion, so confirm the timing for both drugs with the oncologist. It may also reduce fertility, which is worth discussing before treatment if future children matter.

What to Expect

Axitinib is a long-term treatment. It is usually continued for as long as it keeps the cancer under control and side effects remain manageable. In clinical trials, axitinib combined with pembrolizumab helped people with newly diagnosed advanced RCC live longer than sunitinib, an older targeted pill, and with avelumab, tumors shrank in about half of people, roughly double the rate with sunitinib. When used alone after an earlier treatment, axitinib held off cancer growth longer than another targeted drug, sorafenib, typically by a matter of months, and results vary widely from person to person. Scans every few months show whether the cancer is shrinking, stable or growing. Between visits, expect regular blood pressure checks and blood and urine tests for thyroid function, liver health and protein in the urine, a sign of strain on the kidneys' filters that can lead to a dose change if it rises. Doses are often adjusted, up or down, during the first months as the oncologist balances benefit against side effects, and short breaks are sometimes needed. If the cancer grows despite treatment, there are usually other options to consider.

Questions to Ask Your Doctor

  1. 1.Why is axitinib with immunotherapy, or axitinib alone, the right choice for my stage and type of kidney cancer, and what are the alternatives?
  2. 2.What should my blood pressure be at home, how often should I check it, and at what reading should I call you?
  3. 3.Which side effects, such as diarrhea or hand-foot syndrome, can we manage at home, and when would you lower my dose instead?
  4. 4.Do any of my current medicines or supplements interact with axitinib, and what should I do before any surgery or dental work?
  5. 5.How will we know if it is working, and what happens next if the cancer starts growing?

Last reviewed • Oct 2026

Educational content, not medical advice.